Linebacker is one of the Rams' top needs in the draft and there are quality players throughout all seven rounds.

The San Diego Padres managed to bolster their hitting by signing Nick Castellanos, but they’ve yet to address the hole in their starting rotation. With Opening Day coming up fast, they need to find a ...

India’s state-run non-bank lender for housing and urban projects plans to raise $2 billion from multilateral agencies and through foreign-currency borrowing to fund modern infrastructure projects in ...

The New York Mets made a great starting pitching upgrade when they dealt for Freddy Peralta, but they still need to fill one last spot in their rotation. Luckily, there may be someone cost-effective ...

(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...

TSP-1 reduced C3 and C5 cleavage and formation of the membrane attack complex, attenuating complement-mediated injury in AAV models. Complement activation is a relevant driver in the pathomechanisms ...

SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...

The complement system, consisting of three initiating pathways—classical, lectin and alternative, is an important part of innate immunity. Dysregulation of the complement system is implicated in the ...

Abstract: The 2's complement representation is widely adopted, since compared to the other signed number systems has the advantage of simpler addition and single representation of zero. Sing-magnitude ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.